Advertisement
Journal Home
Search for
Cover Image

Current Issue

February 2010 | Vol. 5, No. 2

Top Reports

FDA Approves Liraglutide, With Warning, Caveats

New Osteoporosis Guidelines Use The FRAX Tool

HHS Issues 'Meaningful Use' Criteria for EHRs

Sibutramine Contraindicated in CVD Patients

Bariatric Surgeons Lower BMI Bar for Teens

Outpatient Thyroidectomy Yields Benefits

More Reports >>

GMNN Today's News
audio icon    Policy & Practice
video icon    Videos
Blog    EGMN Blog
facebook      Facebook
twitter      Twitter

Practice Trends

Feds to Study Health Effects of BPA

Policy & Practice

Business Briefs

Daily News from Elsevier Global Medical News

Activate Your Online Access to Clinical Endocrinology News

Sign-up for your free access to Clinical Endocrinology News online. Browse, search, and share full-text articles with colleagues and patients. For the latest news and research reports from medical meetings and expert commentary, sign up or click here for more information.

Already have a username and password? You may be asked to answer a few questions. Click here to log in.

First-time User? Create an account here, and request free access.

Purchase a print subscription now!

Request Free Access to Full-text

RECEIVE FREE EMAIL ALERTS

Register or login to sign up now to receive each issue's table of contents via email as it becomes available.

Add Table of Contents Alert

Stats

Vital Signs: U.S. Health Care Spending Growth Continues to Decelerate

Editorial Advisory Board

 

Best Practices

Preventing Hypoglycemia by Continuous Glucose Monitoring
Sponsored by
Dexcom


A1c Management and Modest Weight Loss in Type 2 Diabetes
Supported by
Amylin/Lilly


MORE

 

Medical Education Library
Identifying Challenges With Insulin Therapy and Assessing Treatment Strategies With Pramlintide
Supported by
Amylin


The Future of Diabetes Care: The Impact of Inhaled Insulin on Glycemic Control
Supported by
Pfizer


MORE

 

Medical Education Library
CASE STUDY: Management Decisions in a Comorbid Patient With Type 2 Diabetes Having Primary Hyperlipidemia
Sponsored by
Daiichi Sankyo, Inc.


MORE

Advertisement